Contact details of Key Managerial Personnel as required under Regulation 30(5) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
PPLPHARMA · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Piramal Pharma has submitted the contact details of its Key Managerial Personnel to the stock exchanges as required under SEBI Listing Regulations. The filing lists two KMPs: Mr. Vivek Valsaraj, Chief Financial Officer, and Ms. Pratibha Mishra, Interim Company Secretary, along with their official email IDs. This is a routine compliance disclosure to enable the company to determine materiality of events and make timely disclosures to the exchanges. The letter is signed by Mr. Vivek Valsaraj in his capacity as Executive Director and CFO, dated 24th February 2026.
This is a standard regulatory compliance filing with no material impact on the company's financials or stock price. The presence of an Interim Company Secretary suggests the role may be temporarily filled, which investors may want to track for permanent appointment news.